Pharmacy Vendor Security Assessment Checklist: How to Evaluate Third‑Party Risk and Compliance

Key Categories of Pharmacy Vendor Security

You need a complete view of how each partner protects patient data and pharmacy operations. Organize your assessments around these key categories so no critical control area is overlooked.

• Governance, risk, and Third‑Party Risk Management (TPRM): oversight, roles, policies, and risk ownership.
• Data protection and privacy: PHI/ePHI classification, encryption, retention, deletion, and Data Protection Impact Assessment (DPIA) needs.
• Identity and access management: least privilege, role design, MFA, SSO, privileged access, and joiner‑mover‑leaver processes.
• Application and cloud security: secure SDLC, SAST/DAST/SCA, SBOM, secrets management, and cloud posture baselines.
• Infrastructure and network security: segmentation, hardening, EDR, vulnerability management, patch SLAs, and logging/monitoring.
• Controlled Substance Security Protocols and EPCS safeguards when vendors touch prescribing workflows or inventory data.
• Physical and environmental security: data center controls, device protections, and media handling.
• Incident response, business continuity, and disaster recovery: tested plans, RTO/RPO, and communications.
• Compliance and assurance: HIPAA/HITECH alignment, SOC 2/ISO certifications, and audit readiness.
• Fourth‑party oversight: subcontractor controls, data flow transparency, and exit planning.

Security Controls and Standards to Verify

Confirm that vendor controls align to recognized frameworks and are evidenced in daily operations. Use the National Institute of Standards and Technology (NIST) Cybersecurity Framework as an anchor across Identify, Protect, Detect, Respond, and Recover.

• Policy and governance: information security policy suite, risk register, and executive reporting mapped to NIST CSF and CIS Controls.
• Access controls: MFA everywhere, RBAC/ABAC, passwordless or strong credential policies, PAM for admin accounts, and quarterly access reviews.
• Encryption and key management: TLS 1.2+ in transit, strong algorithms at rest, HSM/FIPS‑validated modules, and strict key rotation.
• Logging and detection: centralized SIEM, immutable logs, alerting for critical events, and documented escalation paths.
• Vulnerability and patch management: authenticated scanning, prioritized remediation, and proof of timely patching.
• Secure SDLC and change management: code reviews, SAST/DAST, dependency scanning, infrastructure‑as‑code checks, and segregation of duties.
• Data protection controls: DLP, tokenization where appropriate, data minimization, retention schedules, and verifiable deletion.
• Incident readiness: a current Security Incident Response Plan, breach notification playbooks, and periodic tabletop exercises.
• BC/DR: impact analysis, tested backups, documented RTO/RPO, and evidence of recent failover tests.
• Assurance artifacts: SOC 2 Type II, ISO/IEC 27001, HITRUST CSF, HIPAA assessments, and EPCS certification or attestations where applicable.

Risk Evaluation Criteria and Benchmarks

Score vendors consistently by separating inherent risk (what they do and the data they touch) from residual risk (what remains after controls). Define clear thresholds so acceptance decisions are defensible.

• Inherent risk factors: PHI/ePHI volume, controlled substance exposure, integration depth, criticality to dispensing/care, and geographic footprint.
• Control maturity: 0–5 scale across NIST CSF domains; require ≥3 for high‑risk vendors or compensating controls with deadlines.
• Patch and vulnerability SLAs: critical ≤15 days, high ≤30 days, medium ≤60–90 days; no known‑exploited vulns in internet‑facing systems.
• Authentication benchmarks: MFA for all workforce users, hardware‑backed MFA for admins, and just‑in‑time privileged access.
• Resilience targets: RTO ≤4–24 hours and RPO ≤1–24 hours based on service tier; quarterly restore tests for Tier‑1 services.
• Incident expectations: 24‑hour detection‑to‑notification for confirmed breaches affecting PHI; defined roles and contact channels.
• Evidence quality: independent, complete, and current (dated within the last 12 months) with redactions that retain scope and results.
• Risk treatment: remediation plan with owners and dates for any gaps; risk acceptance only within stated appetite and time‑boxed.

Regulatory and Industry Compliance Requirements

Regulations drive minimum safeguards and contract terms. Ensure vendors demonstrate practical compliance, not just policy statements.

• Health Insurance Portability and Accountability Act (HIPAA) and HITECH: Security, Privacy, and Breach Notification Rules; executed BAA; minimum necessary access and audit controls.
• DEA and EPCS: identity proofing, two‑factor authentication for prescribers, logical/physical safeguards, and Controlled Substance Security Protocols in relevant workflows.
• 42 CFR Part 2: heightened confidentiality if substance use disorder information is processed.
• State privacy laws (e.g., CCPA/CPRA, CPA, VCDPA): consumer rights support, data processing addenda, and deletion timelines.
• PCI DSS: if the vendor stores, processes, or transmits cardholder data for pharmacy payments.
• HITRUST CSF or SOC 2 Type II: widely accepted assurance routes that map well to healthcare expectations.
• Interoperability standards: adherence to NCPDP SCRIPT/e‑prescribing requirements and secure API practices where applicable.

Steps for Conducting Vendor Security Assessment

Follow a repeatable workflow so each assessment produces reliable, comparable results. Calibrate reviewers on definitions, scoring, and required evidence before you start.

1. Scope and tier: classify the vendor by data sensitivity, business criticality, and integration level to set the depth of review.
2. Kickoff and NDA: align on architecture, data flows, and timelines; execute confidentiality terms to enable evidence sharing.
3. Issue Vendor Security Questionnaires: use standardized sets (e.g., SIG/CAIQ equivalents) tailored to pharmacy and PHI.
4. Request artifacts: collect SOC/ISO/HITRUST reports, network and data flow diagrams, policies, recent test reports, and training records.
5. Run a DPIA: document lawful basis, purposes, data minimization, retention, sharing, and cross‑border transfers for PHI/ePHI.
6. Validate technical controls: review IAM, encryption, logging, EDR, vulnerability management, and cloud configurations against benchmarks.
7. Assurance testing: examine penetration tests, remediation evidence, and vulnerability trends; sample controls in a guided walkthrough.
8. Incident and resilience: assess the Security Incident Response Plan, breach communications, BC/DR plans, and test results.
9. Score and gap‑remediate: produce a residual risk rating, register findings, assign owners, and agree on remediation dates.
10. Contract safeguards: finalize BAA/DPA, right‑to‑audit, breach notification windows, data location, deletion, and subcontractor approvals.
11. Onboard and baseline: record risk acceptance, define KPIs, and set up continuous monitoring feeds and reporting cadence.

Documentation and Evidence Collection

Ask for precise, recent documents that prove operation, not just intent. Specify acceptable formats and redact guidelines to speed review while preserving substance.

• Assurance reports: SOC 2 Type II (full report), ISO/IEC 27001 certificate and SoA, HITRUST letter of validation, HIPAA assessment summaries.
• Policies and standards: access control, encryption, vulnerability management, change management, data retention, and secure development.
• Architectural evidence: current network and data flow diagrams, asset inventories, cloud account structure, and segmentation details.
• Testing and monitoring: recent penetration test reports, vulnerability scan trends, SIEM alert samples, and log retention proofs.
• IAM artifacts: user and admin access review samples, PAM session records, MFA coverage reports, and joiner‑mover‑leaver logs.
• Privacy and DPIA records: DPIA outputs, data processing addendum, data subject request procedures, and deletion certificates.
• Operational resilience: backup/restore test results, DR exercise summaries with RTO/RPO, and availability SLA performance.
• Workforce safeguards: security awareness and HIPAA training completion, background checks for sensitive roles.
• Regulatory specifics: EPCS/DEA control attestations, Controlled Substance Security Protocols, and any relevant certifications.
• Incident readiness: Security Incident Response Plan, tabletop results, breach notification templates, and contact trees.

Ongoing Monitoring and Reassessment Practices

Risk is dynamic. Establish continuous oversight that combines automated signals with scheduled reviews and clear triggers for deep dives.

• Cadence by tier: high‑risk vendors—quarterly attestations and annual full reviews; medium—semiannual monitoring and annual review; low—annual attestation.
• Trigger‑based reviews: material incidents, major architecture changes, new data types, mergers/acquisitions, or missed SLAs.
• Continuous signals: vulnerability trends, external attack‑surface changes, leaked credential checks, certificate/DMARC posture, and breach intelligence.
• Performance and resilience: ticket and SLA metrics, uptime, DR test outcomes, and closure rates for agreed remediation plans.
• Fourth‑party visibility: inventory of critical subprocessors and verification of their assurance reports.
• Governance: quarterly risk committee updates, refreshed risk ratings, and enforcement of offboarding and verified data deletion at contract end.

By standardizing categories, verifying controls against the NIST CSF, and enforcing evidence‑based scoring, you create a repeatable pharmacy vendor security assessment checklist that reduces real‑world risk while accelerating compliant onboarding.

FAQs.

What are the critical security controls to assess in pharmacy vendors?

Focus on MFA and least‑privilege access, strong encryption with sound key management, continuous logging and SIEM alerting, timely vulnerability and patch management, tested backups with clear RTO/RPO, a current Security Incident Response Plan, and proof of secure SDLC and cloud configurations. For prescribing workflows, confirm EPCS requirements and Controlled Substance Security Protocols.

How do regulatory requirements like HIPAA affect vendor evaluations?

HIPAA sets baseline safeguards for PHI, so you should require a signed BAA, audit trails, access controls, breach notification processes, and workforce training. Map vendor controls to the HIPAA Security Rule and verify practical operation through logs, test results, and monitoring—then layer state privacy and DEA/EPCS requirements as applicable to the service.

What documentation should vendors provide for security assessment?

Request SOC 2 Type II and/or ISO 27001 artifacts, policy and standards documents, network and data flow diagrams, recent penetration tests and vulnerability trends, IAM review samples, DPIA outputs and DPAs, BC/DR test evidence, HIPAA training records, EPCS/DEA attestations if relevant, and the vendor’s Security Incident Response Plan with recent tabletop results.

How often should pharmacy vendor security reassessments be performed?

Use a tiered cadence: high‑risk vendors annually with quarterly attestations; medium‑risk annually with semiannual monitoring; low‑risk at least annually. Always trigger an out‑of‑cycle reassessment after major changes, significant incidents, or when remediation deadlines slip.